Page last updated: 2024-09-02

fingolimod hydrochloride and Diseases of Immune System

fingolimod hydrochloride has been researched along with Diseases of Immune System in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Cohen, JA; McGinley, MP	1
Crespo, MI; García, IA; Gorlino, CV; Harman, MF; Maletto, BA; Morón, G; Pistoresi-Palencia, MC; Ranocchia, RP	1
Mansoor, M; Melendez, AJ	1

Reviews

2 review(s) available for fingolimod hydrochloride and Diseases of Immune System

Article	Year
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. Lancet (London, England), 2021, 09-25, Volume: 398, Issue:10306 Topics: Animals; Azetidines; Benzyl Compounds; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immune System Diseases; Indans; Multiple Sclerosis; Nervous System Diseases; Oxadiazoles; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Thiazoles	2021
Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine. Reviews on recent clinical trials, 2008, Volume: 3, Issue:1 Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Immune System Diseases; Immunosuppressive Agents; Propylene Glycols; Sphingosine	2008

Article

Year

Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions.

Lancet (London, England), 2021, 09-25, Volume: 398, Issue:10306

Topics: Animals; Azetidines; Benzyl Compounds; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immune System Diseases; Indans; Multiple Sclerosis; Nervous System Diseases; Oxadiazoles; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Thiazoles

2021

Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine.

Reviews on recent clinical trials, 2008, Volume: 3, Issue:1

Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Immune System Diseases; Immunosuppressive Agents; Propylene Glycols; Sphingosine

2008

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Diseases of Immune System

Article	Year
Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes. Journal of immunology (Baltimore, Md. : 1950), 2014, Aug-15, Volume: 193, Issue:4 Topics: Adoptive Transfer; Animals; Antigen-Antibody Complex; Cell Movement; Female; Fingolimod Hydrochloride; Immune System Diseases; Immunosuppressive Agents; Inflammation; L-Selectin; Leukocyte Disorders; Lymph Nodes; Lymphatic Vessels; Lymphocyte Function-Associated Antigen-1; Lysophospholipids; Macrophage-1 Antigen; Mice; Mice, Inbred BALB C; Neutrophils; P-Selectin; Propylene Glycols; Receptors, CXCR4; Receptors, Lysosphingolipid; Sphingosine	2014

Article

Year

Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes.

Journal of immunology (Baltimore, Md. : 1950), 2014, Aug-15, Volume: 193, Issue:4

Topics: Adoptive Transfer; Animals; Antigen-Antibody Complex; Cell Movement; Female; Fingolimod Hydrochloride; Immune System Diseases; Immunosuppressive Agents; Inflammation; L-Selectin; Leukocyte Disorders; Lymph Nodes; Lymphatic Vessels; Lymphocyte Function-Associated Antigen-1; Lysophospholipids; Macrophage-1 Antigen; Mice; Mice, Inbred BALB C; Neutrophils; P-Selectin; Propylene Glycols; Receptors, CXCR4; Receptors, Lysosphingolipid; Sphingosine

2014